Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020538 (
hypertension
)
170,190
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The epithelial Na+ channel (ENaC) is a heteromeric protein complex playing a fundamental role in Na+ homeostasis and blood pressure regulation. Specific mutations inactivating PY motifs in ENaC C termini cause Liddle's syndrome, an inherited form of
hypertension
. Previously we showed that these PY motifs serve as binding sites for the E3 enzyme Nedd4-2, implying ubiquitination as a regulatory mechanism of ENaC. Ubiquitination involves the sequential action of E1, E2, and E3 enzymes. Here we identify the E2 enzyme
UBE2E3
, which acts in concert with Nedd4-2, and show by coimmunoprecipitation that
UBE2E3
and Nedd4-2 interact together. In Xenopus laevis oocytes,
UBE2E3
reduces ENaC activity marginally, consistent with Nedd4-2 being the rate-limiting factor in this process, whereas a catalytically inactive mutant of
UBE2E3
(
UBE2E3
-CS) causes elevated ENaC activity by increasing cell surface expression. No additive effect is observed when
UBE2E3
-CS is coexpressed with an inactive Nedd4-2 mutant, and the stimulatory role of
UBE2E3
-CS depends on the integrity of the PY motifs (Nedd4-2 binding sites) and the ubiquitination sites on ENaC. In renal mpkCCD(cl4) cells, displaying ENaC-dependent transepithelial Na+ transport, Nedd4-2 and
UBE2E3
can be coimmunoprecipitated and overexpression of
UBE2E3
affects Na+ transport, corroborating the concept of a concerted action of
UBE2E3
and Nedd4-2 in ENaC regulation.
...
PMID:Participation of the ubiquitin-conjugating enzyme UBE2E3 in Nedd4-2-dependent regulation of the epithelial Na+ channel. 1499 79